Device Hips

Synovasure Alpha Defensin

Payments companies reported to CMS as associated with Synovasure Alpha Defensin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$38Kassociated payments (2023-2025)
67clinicians with associated payments
1company reporting

By year

2023 $243
2024 $13K
2025 $25K

Payments reported as associated with Synovasure Alpha Defensin, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Adult Reconstructive Orthopaedic Surgery $22K
Orthopaedic Surgery $13K
Infectious Disease $1,857
Family Medicine $495
Orthopaedic Trauma $372
Sports Medicine (Family Medicine) $247

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Synovasure Alpha Defensin

These are the largest totals companies reported as associated with Synovasure Alpha Defensin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Richard Purcell El Paso, TX Adult Reconstructive Orthopaedic Surgery $14,750.00
Carl Deirmengian Limerick, PA Orthopaedic Surgery $5,186.27
Paul Edwards Little Rock, AR Adult Reconstructive Orthopaedic Surgery $4,750.00
Edward Mcpherson Los Angeles, CA Orthopaedic Surgery $3,387.82
Laura Certain Boston, MA Infectious Disease $1,856.96
Alberto Carli New York, NY Adult Reconstructive Orthopaedic Surgery $877.51
Peter Sculco New York, NY Adult Reconstructive Orthopaedic Surgery $727.83
John Sperling Rochester, MN Orthopaedic Surgery $660.80
Javad Parvizi Philadelphia, PA Adult Reconstructive Orthopaedic Surgery $241.00
Dustin Morgan Buffalo, NY Orthopaedic Surgery $198.95

Prescribed Synovasure Alpha Defensin?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.